Literature DB >> 33998217

[Study on the correlation between the content of bone morphogenetic protein 2 in demineralized bone matrix and its osteogenic activity in vitro and in vivo].

Miao Li1, Yulong Bai1, Xiaoliang Pan2, Jingjing Wang3, Weiming Chen3, Jingwan Luo3, Kai Hu3, Jinfa Chen3.   

Abstract

OBJECTIVE: To investigate the correlation between the content of bone morphogenetic protein 2 (BMP-2) in demineralized bone matrix (DBM) and its osteogenic activity in vitro and in vivo, in order to choose a simple and convenient method to evaluate the osteogenic activity of DBM.
METHODS: The left mid-femoral tissues of 9 donors were taken, and DBMs (S1-S9) were prepared by dynamic decalcification process, and inactivated DBM (control group) was prepared at the same time. Protease inhibitor method, collagenase method, guanidine hydrochloride/ethylene diamine tetraacetic acid (EDTA) method, and RIPA lysate method were used to extract BMP-2 in S1-S9 and inactivated DBMs. The BMP-2 content was measured and the differences between DBMs were compared. Then the S1-S9 and inactivated DBMs were co-cultured with mouse embryonic osteoblasts MC3T3-E1, respectively. The cell proliferation was detected by MTT method and fluorescence staining, and alkaline phosphatase (ALP) activity was detected at the same time. Thirty BALB/c male nude mice were divided into 10 groups, namely S1-S9 DBM groups (S1-S9 groups) and inactivated DBM group (control group), with 3 mice in each group. Muscle pockets of the middle thighs were prepared on both hindlimbs of mice in each group, and implanted corresponding DBM materials. At 4 weeks after operation, the samples were taken for HE staining observation and semi-quantitative evaluation, and the new bone formation score was calculated.
RESULTS: The BMP-2 content of DBM derived from different donor bones was distinct. The BMP-2 content obtained by different extraction methods for DBM prepared from the same donor bone was also different, and the extraction efficiency of the guanidine hydrochloride/EDTA method was the highest. In vitro cell experiments, MTT test displayed that cell proliferations and ALP activity were significantly higher in S4 and S6 groups than in other groups at each time point after co-cultivation ( P<0.05). Moreover, the cell proliferation of S4 group was the most significant at 7 days ( P<0.05); fluorescence staining demonstrated that the osteoblasts of each group was in good condition, but the osteoblasts of S1, S2, S3, S4, and S6 groups were significantly more than other groups. In vivo ectopic osteogenesis experiments, the cartilage and new bone formation could be seen in the bone graft area of S1-S6 groups at 4 weeks after operation, and with the increase of BMP-2 content, the more new bone formation induced by the material, the higher the score of new bone formation of the material ( P<0.05). Among them, S4 and S6 groups contained a large number of chondrocytes and osteoblasts in the osteogenesis area.
CONCLUSION: The osteogenic activity of DBM can be evaluated through BMP-2 quantitative detection combined with in vitro osteoblast proliferation and differentiation experiments.

Entities:  

Keywords:  Demineralized bone matrix; bone morphogenetic protein 2; guanidine hydrochloride/ethylene diamine tetraacetic acid; osteogenic activity

Mesh:

Substances:

Year:  2021        PMID: 33998217      PMCID: PMC8175199          DOI: 10.7507/1002-1892.202012006

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  14 in total

1.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs).

Authors:  Hongwei Cheng; Wei Jiang; Frank M Phillips; Rex C Haydon; Ying Peng; Lan Zhou; Hue H Luu; Naili An; Benjamin Breyer; Pantila Vanichakarn; Jan Paul Szatkowski; Jae Yoon Park; Tong-Chuan He
Journal:  J Bone Joint Surg Am       Date:  2003-08       Impact factor: 5.284

2.  Extractable bone morphogenetic protein and correlation with induced new bone formation in an in vivo assay in the athymic mouse model.

Authors:  Sittisak Honsawek; Ralph M Powers; Lloyd Wolfinbarger
Journal:  Cell Tissue Bank       Date:  2005       Impact factor: 1.522

3.  Bone: formation by autoinduction.

Authors:  M R Urist
Journal:  Science       Date:  1965-11-12       Impact factor: 47.728

Review 4.  Preclinical and clinical evaluation of osteogenic protein-1 (BMP-7) in bony sites.

Authors:  S D Cook
Journal:  Orthopedics       Date:  1999-07       Impact factor: 1.390

5.  Measurement of total and local bone morphogenetic protein concentration in bone tumours.

Authors:  M Laitinen; L Jortikka; T Halttunen; J Nevalainen; A J Aho; A Marttinen; T S Lindholm
Journal:  Int Orthop       Date:  1997       Impact factor: 3.075

Review 6.  Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling.

Authors:  P J Marie; F Debiais; E Haÿ
Journal:  Histol Histopathol       Date:  2002       Impact factor: 2.303

7.  Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation.

Authors:  T K Sampath; A H Reddi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

8.  Measurement of bone morphogenetic proteins and other growth factors in demineralized bone matrix.

Authors:  Barbara Blum; Jon Moseley; Leasa Miller; Kelly Richelsoph; Warren Haggard
Journal:  Orthopedics       Date:  2004-01       Impact factor: 1.390

9.  The classic: Bone morphogenetic protein.

Authors:  Marshall R Urist; Basil S Strates
Journal:  Clin Orthop Relat Res       Date:  2009-12       Impact factor: 4.176

Review 10.  Bone grafts and biomaterials substitutes for bone defect repair: A review.

Authors:  Wenhao Wang; Kelvin W K Yeung
Journal:  Bioact Mater       Date:  2017-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.